NNMT (nicotinamide N-methyltransferase, E.C. 2.1.1.1) catalyses the N-methylation of nicotinamide to 1-methylnicotinamide. NNMT expression is significantly elevated in a number of cancers, and we have previously demonstrated that NNMT expression is significantly increased in the brains of patients who have died of Parkinson's disease. To investigate the cellular effects of NNMT overexpression, we overexpressed NNMT in the SH-SY5Y cell line, a tumour-derived human dopaminergic neuroblastoma cell line with no endogenous expression of NNMT. NNMT expression significantly decreased SH-SY5Y cell death, which correlated with increased intracellular ATP content, ATP/ADP ratio and Complex I activity, and a reduction in the degradation of the NDUFS3 [NADH dehydrogenase (ubiquinone) iron-sulfur protein 3] subunit of Complex I. These effects were replicated by incubation of SH-SY5Y cells with 1-methylnicotinamide, suggesting that 1-methylnicotinamide mediates the cellular effects of NNMT. Both NNMT expression and 1-methylnicotinamide protected SH-SY5Y cells from the toxicity of the Complex I inhibitors MPP+ (1-methyl-4-phenylpyridinium ion) and rotenone by reversing their effects upon ATP synthesis, the ATP/ADP ratio, Complex I activity and the NDUFS3 subunit. The results of the present study raise the possibility that the increase in NNMT expression that we observed in vivo may be a stress response of the cell to the underlying pathogenic process. Furthermore, the results of the present study also raise the possibility of using inhibitors of NNMT for the treatment of cancer.
INTRODUCTION
The correct functioning of the mitochondria is essential for the production of ATP from NADH via oxidative phosphorylation within the inner mitochondrial membrane. CxI (Complex I) deficiency has been implicated in the pathogenesis of PD (Parkinson's disease) [1] . Nicotinamide, a form of vitamin B3, is the precursor for NAD+ synthesis [2] , and plays a crucial role in cell survival and longevity [3] . NNMT (nicotinamide N-methyltransferase, E.C. 2.1.1.1) catalyses the N-methylation of nicotinamide to MeN (1-methylnicotinamide) and is one of a family of three N-methyltransferases which share close sequence similarity [4] . NNMT is an S-adenosylmethionine-dependent enzyme with a molecular mass of 29 kDa [5] which is present within a variety of tissues, the highest expression of which is in the liver [6] . NNMT expression in the brain is solely neuronal and there is a wide variation in the level of expression in the brain [6] . NNMT expression in both liver and brain follows a bimodal frequency distribution, with 25 % of subjects in a high-activity subgroup [6, 7] .
We have previously demonstrated increased expression of NNMT in the brains of patients who have died of PD, with a significant correlation between the level of a patient's NNMT expression and their disease duration [6, 8] , suggesting a causative effect in the pathogenesis of the disease. NNMT is also overexpressed in a number of cancers, such as pancreatic [9] , bladder [10] , lung [11] and gastrointestinal [12] cancers, and squamous cell carcinoma [13] , and it has been suggested that NNMT expression can be used as a prognostic marker for cancer [13, 14] .
Studies using rat and bovine brain have shown that MeN is toxic to neurons of the substantia nigra, resulting in damage to the 30 kDa subunit of CxI {henceforth referred to as NDUFS3 [NADH dehydrogenase (ubiquinone) iron-sulfur protein 3]} via the production of free radicals [15] and dopamine depletion [16] . In contrast, other studies using CGCs (cerebellar granule cells) show that MeN is neuroprotective against excitotoxins, such as glutamate, although the authors described this neuroprotection as being weak at best [17, 18] . MeN has been shown to be beneficial in conditions such as inflammation [19] , hepatotoxicity [20] and thrombosis [19] .
In the present study we set out to investigate the cellular effects of NNMT expression using the human neuroblastomaderived cell line SH-SY5Y. Crucially, this cell line has no endogenous expression of NNMT, therefore allowing us to study directly the effect of NNMT expression upon cell viability and to investigate whether the effects of NNMT are mediated by MeN.
MATERIALS AND METHODS
Unless otherwise stated, all materials were obtained from Sigma and were of the highest purity available.
NNMT plasmid construction and stable mammalian expression
SH-SY5Y human neuroblastoma cells were obtained from the European Collection of Animal Cell Cultures (Porton Down, U.K.) at passage number 16 and cultured as described previously [21] . All experiments were performed using undifferentiated cells of passage number [18] [19] [20] . The NNMT plasmid construct (pNNMT) was produced by ligating a cDNA encoding NNMT Cterminally fused to a V5 fusion tag into the pcDNA3.1 TM -TOPO ® mammalian expression vector (Invitrogen). The primer pair used was the following: forward primer, 5 -CACCATGGAATCA-GGCTTCACCTCC-3 and reverse primer, 5 -TCCTCTTCC-AAGCAGGGGTCTGCTCAGCTTC-3 . pNNMT plasmid was transfected in SH-SY5Y cells using PolyPlus jetPEI transfection reagent (Autogen Bioclear). Stable transfectants were selected using Geneticin (250 μg/ml; Invitrogen), and NNMT-V5 mRNA expression was confirmed using RT (reverse transcription)-PCR using the following primer pair: forward primer, 5-TGGCCCCACTATCTATCAGC-3 , and reverse primer, 5 -CCTCTTTCACAGCAGCCTCT-3 . β-Actin was used as a loading control, detected using the following primer pair: forward primer, 5 -GGCATCCTCACCCTGAAGTA-3 , and reverse primer 5 -GGGTGTTGAAGGTCTCAAA-3 . Recombinant NNMT-V5 expression was confirmed using SDS/PAGE and Western blotting [6, 8] using a combination of mouse anti-V5 antibody (1:2000 dilution; Abcam) and anti-mouse IgG conjugated to HRP (horseradish peroxidase) (1:2000 dilution). Protein loading was normalized using mouse anti-β-actin (1:1000 dilution; Autogen Bioclear). Detected bands were visualized using ECL (enhanced chemiluminescence) (GE Healthcare). Enzyme activity of NNMT-V5 was confirmed using a radioassay described previously [6] . NNMT activity was calculated and expressed as the specific activity (nmol of MeN produced/hour per mg of protein) + − S.D. SH-SY5Y cells expressing NNMT were named S.NNMT.LP and were used for all subsequent analyses.
Cell death assays
Cell death was measured using the Cytotoxicity Detection Kit ® [using LDH (lactate dehydrogenase)] (Roche Diagnostics) [21] . Cell death was calculated as the percentage cell death + − S.D. Cellular apoptosis was measured by analysing caspase activation using the fluorescence-based Caspase-Glo ® 3/7 assay kit (Promega) [21] ; the assay relies upon the cleavage of a fluorescence resonance energy transfer-quenched substrate by caspases 3 and 7 upon activation of apoptosis. Results were expressed as the percentage change in apoptosis compared with untreated cells + − S.D.
Cell proliferation assay
Cell proliferation was measured by assaying cell number using total cellular LDH content. Cells were plated at an equal density into 24-well plates and allowed to settle overnight. Baseline LDH content was obtained by lysing cells into the culture medium by the addition of Triton X-100 [1 % (v/v) final concentration]. Further samples were incubated for an additional 24 h, after which time cells were lysed, centrifuged at 14 000 g for 5 min to precipitate particulate material, and LDH was measured in recovered supernatant as described above. Cell proliferation was calculated by dividing the LDH released from cells cultured for 24 h by the baseline LDH value and was expressed as proliferation ratio + − S.D.
Intracellular indices of energy production
ATP and ADP concentrations were measured by bioluminescence using the luciferin/luciferase reaction-based ApoGlow ® ATP/ADP assay kit (Lonza), according to the manufacturer's instructions. Results were expressed as pmol/mg of protein + − S.D. and as the ATP/ADP ratio + − S.D.
Pyridine nucleotide concentrations were measured using the method described by Queval and Noctor [22] with the use of 0.2 M HCl supplemented with 1 % (v/v) Tween 20 instead of 0.2 mM HCl for the measurement of NADH, and 0.2 M NaOH supplemented with 1 % (v/v) Tween 20 instead of NaOH for the measurement of NAD+. Absorbance was measured at 595 nm every 30 s for 10 min at room temperature (22 • C). Results were plotted and calculated as A 595 /min and converted into pmoles using a standard curve constructed from 0 to 40 pmol of appropriate pyridine nucleotide. Samples were corrected for volume and finally expressed as both μM pyridine nucleotide + − S.D. and the NAD+/NADH ratio + − S.D.
Mitochondrial membrane potential and oxygen consumption
Mitochondrial membrane potential was measured using the fluorescence-based JC-1 Mitochondrial Membrane Potential Assay Kit (Cayman Chemical Company) in a 96-well plate format, according to the manufacturer's instructions. Results were calculated and expressed as the red/green fluorescence ratio + − S.D. Oxygen consumption in unstimulated cells and in the presence of oligomycin and 2,4-dinitrophenol was measured using a Clarke oxygen electrode using the method described by Kwok et al. [23] . Results were calculated and expressed as the rate of oxygen consumption/min per mg of protein + − S.D.
CxI activity analysis
Mitochondria were isolated from cells lysed in an ice-cold homogenization buffer comprising 0.25 mM sucrose, 10 mM Tris/HCl and 1 mM sodium EDTA (pH 7.4). Lysed membranes and nuclei were pelleted by centrifugation at 1500 g for 12 min at 4
• C. Mitochondria were isolated from the supernatant by centrifugation at 14 000 g for 12 min at 6
• C and resuspended in homogenization buffer. CxI was measured in cell samples using the method described by Janssen et al. [24] in a 96-well plate format. Rotenone-sensitive CxI activity was calculated and normalized for mitochondrial number using CS (citrate synthase) activity [24] . CS activity was calculated and used to normalize CxI activity, which is henceforth referred to simply as CxI activity. CxI activity was expressed as a percentage of CxI activity observed in untreated SH-SY5Y cells + − S.D.
Real-time qPCR (quantitative PCR) analysis of NDUFS3 expression
mRNA expression was quantified using real-time qPCR using the UPL (Universal Probe Library) as internal quantification probes (Roche). NDUFS3 expression was detected using primers and the appropriate UPL (Roche) as outlined in Table 1 . qPCR was performed using an ABI Prism 7000 thermal cycler (Applied Biosystems) using FastStart Universal Probe Master Mix (Roche) and the following cycling conditions: 95
• C for 10 min, followed by 40 cycles of 95
• C for 15 s and 60
• C for 1 min. The NNMT enzyme activity was detected using a radioimmunoassay as described previously [6] . Bottom panel: effect of NNMT expression upon cell death. Cell death was measured using LDH release.
housekeeping genes β-actin and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) ( Table 1) were used to normalize mRNA expression, and results were expressed as the percentage expression compared with that observed in untreated SH-SY5Y cells + − S.D. The presence of single bands in each sample was subsequently confirmed using DNA gel electrophoresis.
Western blot analysis of NDUFS3 protein expression
Protein samples were prepared, the protein concentration was quantified and samples were subjected to Western blotting. NDUFS3 was detected using a combination of mouse anti-NDUFS3 (1:2000 dilution; Invitrogen) at 4
• C and rabbit anti-mouse IgG (conjugated to HRP, 1:5000 dilution). Membranes were stripped using Restore Western Stripping Reagent (Fisher Scientific) and re-probed using anti-β-actin.
Images were digitally captured and band intensities were quantified using densitometric analysis using the GeneTools image analysis software (Syngene) and normalized for β-actin expression. Results were calculated and expressed as the ratio of the intensity observed in untreated SH-SY5Y cells + − S.D., with each protein in untreated SH-SY5Y cells having a ratio of 1. concentration reported to be neurotoxic by Fukushima and colleagues (15-20 mM) [15, 16] . The effect of leupeptin upon NDUFS3 expression was investigated using Western blotting in undifferentiated SH-SY5Y cells incubated with 0, 25, 50 and 100 μg/ml leupeptin for 24 h at 37
• C.
Statistical analysis
All statistical analyses were performed using the Instat statistical package (GraphPad) and were performed using one-way ANOVA with post-hoc Tukey comparisons. The exceptions to this were (i) the statistical analysis of qPCR data, (ii) the comparison of NNMT activity in SH-SY5Y and S.NNMT.LP cells, and (iii) the effect of NNMT expression upon SH-SY5Y cell death and proliferation, for which a Student's t test with Welch correction was used. P values of less than 0.05 were considered significant.
RESULTS
The expression of NNMT-V5 reduced SH-SY5Y cell death S.NNMT.LP cells stably expressed both NNMT-V5 protein and NNMT mRNA, neither of which was present in the wild-type SH-SY5Y cell line ( Figure 1A ). Calculation of the molecular mass for NNMT-V5 revealed a protein of 32 kDa, which taking into account the presence of the V5 epitope is in accordance with the 29 kDa size for NNMT [5, 11] . NNMT-V5 was catalytically active in S.NNMT.LP cells at a level of activity similar to that observed in PD cerebellum [6] . Cell death was significantly lower in S.NNMT.LP cells compared with SH-SY5Y cells ( Figure 1B , bottom panel, n = 6).
MeN reduced SH-SY5Y cell death
Incubation of SH-SY5Y cells with increasing concentrations of MeN reduced cell death ( Figure 2A , n = 6 for all incubations). In order to discount the possibility that MeN may be interfering with the LDH assay, we also measured cellular apoptosis ( Figure 2B ). Cellular apoptosis also significantly decreased with increasing MeN concentration (n = 6 for all incubations). It was possible that the apparent decrease in cell death observed may be due to increased cell proliferation. To investigate this, we compared the proliferation ratio of SH-SY5Y cells with both S.NNMT.LP cells and SH-SY5Y cells incubated with 1 mM MeN. The proliferation ratios for SH-SY5Y and S.NNMT.LP cells were not significantly different (1.61 + − 0.17, P = 0.1446, n = 6). Incubation with 1 mM MeN also did not alter the proliferation ratio, being 1.53 + − 0.016, 1.47 + − 0.007, 1.45 + − 0.018 and 1.51 + − 0.069 for 0.1, 0.25, 0.5 and 1 mM MeN respectively (n = 6 for all incubations).
Both NNMT expression and incubation with 1 mM MeN increased ATP production, the ATP/ADP ratio and CxI activity, and reduced the NAD+/NADH ratio In S.NNMT.LP cells the ATP/ADP ratio was approximately 4-fold higher compared with that in SH-SY5Y cells ( Figure 3A , n = 6), which was due to a significant increase in ATP concentration ( Figure 3B ) and a significant decrease in ADP concentration ( Figure 3C ). Likewise, the ATP/ADP ratio in SH-SY5Y cells incubated with 1 mM MeN also significantly increased compared with untreated SH-SY5Y cells ( Figure 3A , n = 6), as was the intracellular ATP concentration ( Figure 3B ), although ADP concentration was not significantly different ( Figure 3C ). There was a corresponding 4-fold increase in CxI activity in S.NNMT.LP cells compared with that observed in SH-SY5Y cells, along with a significant increase observed in SH-SY5Y cells incubated with 1 mM MeN ( Figure 3D , n = 6). Oxygen consumption increased significantly in SH-SY5Y cells incubated with 1 mM MeN and in S.NNMT.LP cells ( Figure 3E , n = 4), which decreased in the presence of oligomycin and increased in the presence of 2,4-dinitrophenol ( Figure 3F , n = 4). The mitochondrial membrane potential did not significantly alter in either incubation condition, although incubation of SH-SY5Y with 1 mM 2,4-dinitrophenol significantly reduced the mitochondrial membrane potential ( Figure 3G , n = 3).
It is possible that these changes may have arisen from alterations in NADH availability. To assess this, we measured pyridine nucleotide concentrations and the NAD+/NADH ratio. The NAD+ concentration in S.NNMT.LP cells was significantly reduced compared with SH-SY5Y cells ( Figure 4A , n = 4), with a smaller, yet still significant, reduction in the NADH concentration in S.NNMT.LP cells ( Figure 4B , n = 4). Consequently, the NAD+/NADH ratio was significantly reduced in S.NNMT.LP cells compared with SH-SY5Y cells ( Figure 4C ). Incubating SH-SY5Y cells with 1 mM MeN had no effect upon the NAD+ concentration compared with untreated SH-SY5Y cells ( Figure 4A , n = 4), although there was a significant increase in the NADH concentration ( Figure 4B, n = 4) . Consequently, the NAD+/NADH ratio was lower in SH-SY5Y cells incubated with 1 mM MeN compared with that in untreated cells ( Figure 4C , n = 4).
NNMT expression and incubation with 1 mM MeN increased the expression of NDUFS3-immunoreactive proteins
We next investigated whether the effects we had observed were due to alterations in CxI subunit expression directly. In particular, we chose NDUFS3 because of the reported interaction (G) Mitochondrial membrane potential. Mitochondrial membrane potential was measured using the JC-1 red/green ratio. Statistical analysis comprised the comparison of untreated SH-SY5Y with both SH-SY5Y incubated with 1 mM MeN and untreated S.NNMT.LP. n/s, not significant; *P < 0.05; **P < 0.01; ***P < 0.001. In (F and G) 2,4-DNP is 2,4-dinitrophenol.
between MeN and NDUFS3 [15, 16] . NDUFS3 immunoreactivity was observed in three proteins of 39 kDa, 45 kDa and 50 kDa ( Figure 5A ). The intensity of the 39 kDa band was significantly higher than both the 45 kDa and 50 kDa bands. The expression of all three bands was increased in S.NNMT.LP cells compared with SH-SY5Y cells. The expression of all three bands also increased with increasing MeN concentration ( Figure 5B) , with peak expression observed at 0.5 mM MeN ( Figure 5C , top panel, n = 4). The increase in expression of the 45 kDa and 50 kDa bands was much more marked, with the maximal increase for both also observed after incubation with 0.5 mM MeN ( Figure 5C , bottom panel, n = 4 for both).
NDUFS3-immunoreactive proteins are subcellular localization-specific
Having shown using Western blotting that NDUFS3 immunoreactivity was present in three bands, we decided to determine whether these immunoreactive proteins were subcellular localization-specific using isolated mitochondria and post-mitochondrial supernatant (cytosol) ( Figure 6 ). As previously observed, all three bands were present in SH-SY5Y cell lysate, with the 39 kDa band present solely in mitochondrial lysate, and the 45 and 50 kDa bands present solely in the postmitochondrial supernatant. No other immunoreactive bands were 
NNMT expression and incubation with 1 mM MeN did not alter NDUFS3 mRNA expression
To determine whether these increases in NDUFS3 protein expression were due to increased protein synthesis arising from increased mRNA expression, we measured NDUFS3 mRNA expression in SH-SY5Y cells, S.NNMT.LP cells and SH-SY5Y cells incubated with 1 mM MeN using qPCR. NDUFS3 mRNA expression was not significantly different in S.NNMT.LP cells compared with that observed in SH-SY5Y cells (100 + − 2.3 % compared with 94.1 + − 6.13 %, P = 0.7830, n = 3). Likewise, NDUFS3 expression was not significantly altered in SH-SY5Y cells following incubation with 1 mM MeN (100 + − 2.8 % compared with 79.2 + − 7.93 %, P = 0.3302, n = 3).
Inhibiting proteolysis increased NDUFS3 protein expression
As the increases in NDUFS3 expression that we observed did not arise from an increase in mRNA expression, it is possible that this may have arisen from increased protein production or decreased protein catabolism. To investigate this, we inhibited lysosomal protein degradation using leupeptin [27] . All three NDUFS3-immunoreactive bands were observed in untreated SH-SY5Y cells, all of which increased significantly in expression with increasing leupeptin concentration ( Figure 7A) , with a maximal increase observed in cells incubated with 50 μg/ml leupeptin ( Figure 7B , bottom panel, n = 4).
NNMT expression and incubation with 1 mM MeN reduced the toxicity of the CxI inhibitors MPP+ and rotenone
Having demonstrated that NNMT expression increased cell viability which coincided with the induction of CxI activity, and that this effect appeared to be mediated via a reduction in NDUFS3 degradation, we next decided to investigate whether NNMT may protect against the toxicity of the CxI inhibitors MPP+ and rotenone (Figure 8 Having demonstrated that NNMT expression protected against the toxicity of MPP+ and rotenone, it was decided to investigate whether MeN replicated these effects. Co-incubation of 0.5 mM MPP+ and 0.4 μM rotenone with 1 mM MeN significantly reduced the toxicity of both CxI inhibitors towards SH-SY5Y cells, both of which were not significantly different to the degree of cell death observed in untreated SH-SY5Y cells ( Figure 9A , n = 6 for all incubations).
We next investigated whether the cytoprotective effects of MeN were mediated by changes in ATP and ADP concentrations, the ATP/ADP ratio, CxI activity and NDUFS3 expression. Both 0.5 mM MPP+ and 0.4 μM rotenone reduced ATP concentration and increased ADP concentration which resulted in a decrease in the ATP/ADP ratio compared with that observed in untreated cells, which was reversed by co-incubation with 1 mM MeN (n = 6 for all incubations). Likewise, MPP+ and rotenone decreased CxI in SH-SY5Y cells, which co-incubation with 1 mM MeN reversed back to levels which were not significantly different to those observed in untreated SH-SY5Y cells ( Figure 9E , n = 6 for both). Cellular oxygen consumption decreased significantly in response to MPP+ and rotenone, which was reversed by co-incubation with 1 mM MeN ( Figure 9F , n = 4 for all incubations). Oxygen consumption under all conditions decreased and increased in response to oligomycin and 2,4-dinitrophenol respectively ( Figure 9G ). The mitochondrial membrane potential also altered in a similar manner to that observed for oxygen consumption ( Figure 9H, n = 3) . Both the 45 kDa and 50 kDa NDUFS3-immunoreactive proteins were absent in SH-SY5Y cells incubated with MPP+ and rotenone, which was reversed by coincubation with 1 mM MeN ( Figure 9I ).
DISCUSSION

NNMT expression reduced cell death by increasing CxI activity
A number of studies have shown that NNMT is overexpressed in a variety of diseases [9] [10] [11] [12] [13] [14] . None of these studies have addressed why, nor have they provided any mechanistic insights into why NNMT may have a role in disease progression. In the present study we demonstrate that NNMT expression is involved in maintaining cell viability by increasing CxI activity, and that this appears to be mediated via the protection of NDUFS3 from degradation. Furthermore, we have shown that these effects arise due to the increased production of MeN, as incubation of cells with 1 mM MeN replicates all of the effects of NNMT upon cell viability. Finally, we demonstrate that NNMT and MeN are cytoprotective against the CxI inhibitors MPP+ and rotenone, and that this is mediated via the maintenance of CxI activity arising from the protection of NDUFS3 from inhibitor-mediated damage.
Our previous studies using post mortem brain tissue demonstrated that NNMT levels are significantly higher in PD compared with non-PD patients. This, in tandem with an inverse correlation between disease duration and protein expression level, suggested a causative role for NNMT in the pathogenesis of PD [6, 8] . This was supported by two studies which suggested that MeN is neurotoxic via the induction of free radicals similar in mechanism to that of paraquat, causing the destruction of NDUFS3 [15] and striatal dopamine depletion [16] . However, these studies had used MeN concentrations of 15-20 mM, which are significantly higher than those found endogenously within the brain [28] and which have been shown to be significantly toxic towards macrophages [26] . Other studies have shown that 1 mM is not toxic to primary CGCs, with toxicity only manifesting at concentrations of 100 mM [23] . Additionally, an intracellular MeN concentration of 500 μM did not result in the death of hippocampal neurons in the rat brain in vivo [28] .
Our original hypothesis was that overexpression of NNMT leads to a reduction in available nicotinamide for NADH synthesis, and that such a reduction in NADH synthesis may impinge upon the ability of the cell to produce ATP, therefore leading to a reduction in cellular energy levels and thus reducing cell viability and/or reducing the ability of the cell to survive a subsequent cytotoxic challenge. One hurdle to this hypothesis was that NNMT overexpression is a common feature in many cancers, which do not demonstrate reduced cell viability but instead demonstrate increased proliferative capacity. To gain an insight into the potential consequences of NNMT expression that we have previously observed in patient brain samples [6, 8] , we ectopically expressed NNMT in a commonly used in vitro neuroblastoma cell line which would allow us to investigate the mechanism underlying the effects of NNMT upon the cell. What makes this cell line particularly useful is that it has no endogenous expression of NNMT, thus allowing us to directly quantify the effect that NNMT expression has upon the cell. It is also a tumourderived cell line, therefore it is also relevant to studying the role of NNMT in cancer.
Expression of NNMT in the SH-SY5Y cell line significantly reduced cell death, which was replicated by incubation with MeN. The decreases in cell death that we observed correlated with increases in the ATP/ADP ratio and CxI activity. Various ATP/ADP ratios have been quoted in the literature for in vitro cell systems. The ATP/ADP ratio that we observed is similar to those reported for SH-SY5Y cells and other in vitro human cell lines [29] [30] [31] . The increases in ATP concentration and ATP/ADP ratio coincided with similar increases in CxI activity, therefore we concluded that it was likely that NNMT and MeN increased cell viability via increased CxI activity, resulting in an increased ATP concentration. Increases in ATP levels have been shown to rescue neurons from toxicity in several dopaminergic model systems [32] [33] [34] , and is likely to be responsible for the decrease in cell death that we observed.
The effects of NNMT expression and MeN are mediated via CxI
Having identified that NNMT expression increased CxI activity, the next question we addressed was the mechanism by which this occurred. Alterations in NAD+/NADH ratio could conceivably alter electron flow through the mitochondrial respiratory chain, therefore significant increases in NADH availability may increase ATP synthesis. However, as nicotinamide is a precursor for pyridine nucleotide synthesis, we expected NADH and NAD+ concentrations to be significantly lower in the S.NNMT.LP cell line than in the parental SH-SY5Y cells. As expected, we observed a decrease in the NAD+/NADH ratio which arose from a small decrease in NADH concentration and a very significant decrease in NAD+ concentration. Although global pyridine nucleotide synthesis is significantly reduced, as evidenced by the significantly lower NAD+ levels in S.NNMT.LP cells, the regeneration of NADH via the tricarboxylic acid cycle is not compromised, as NADH concentrations were not sufficiently reduced to have a negative impact upon ATP synthesis.
Another mechanism that we investigated was an interaction with the NDUFS3 subunit of CxI. CxI is a supercomplex of 45 subunits derived from both nuclear and mitochondrial DNA [35] . NDUFS3 is one of three nuclear DNA-encoded iron-sulfur protein subunits of CxI, the incorporation of which occurs early in CxI assembly by the sequential association of NDUFS3 with other subunit proteins [35, 36] . We investigated NDUFS3 because studies using rat brain have shown that 15-20 mM MeN destroyed NDUFS3 via the production of free radicals in a mechanism similar to that of paraquat [15] . There are a number of problems with the abovementioned study. The concentrations of MeN used in the study were 10-100-fold greater than the 1 mM used in our present study, which the majority of studies investigating the cellular effects of MeN have also used [17, 18, 25, 26] . Also, their analysis of CxI subunit abundance was made using Coomassie Brilliant Blue staining of the mitochondrial fraction separated using SDS/PAGE, which, because of the number of proteins present in the sample and their inability to conclusively identify subunits without the use of specific antibodies, makes it difficult to identify the NDUFS3 subunit. Finally, the lack of a protein loading control such as β-actin makes it very difficult to quantify any changes that the authors observed. Using an antibody specific to NDUFS3, we observed that NDUFS3 immunoreactivity was present in a major protein of 39 kDa plus two other bands of 45 kDa and 50 kDa. It is likely that this 39 kDa protein is monomeric NDUFS3 and that the 45 kDa and 50 kDa proteins are NDUFS3 having either undergone post-translational modification or becoming tightly associated with other proteins as part of an assembly complex. One such candidate is prohibitin, a chaperonin shown to protect CxI subunits before assembly [37] , which binds directly to NDUFS3 [38] . The reason for the subcellular fraction specificity of these proteins is unclear, but it may be related to the localization of the NDUFS3 gene to the nuclear DNA, resulting in the production of a cytosolic protein which undergoes translocation to the mitochondria.
Our use of a specific anti-NDUFS3 antibody also showed that the abundance of all three of these proteins increased with increasing MeN concentration. Although we have not fully characterized the identity of each of the NDUFS3-immunoreactive proteins, it is likely that they have functional relevance upon CxI activity, as their increase in expression correlated with an increase in CxI activity and ATP synthesis. Furthermore, we were able to remove the 50 and 45 kDa proteins by incubating SH-SY5Y cells with MPP+ and rotenone, and subsequently reverse this by co-incubating with MeN. Most significantly, these changes correlated with alterations in ATP synthesis, the ATP/ADP ratio and the CxI ratio; in the absence of the 45 kDa and 50 kDa proteins, the ADP concentration increased, whereas ATP concentration, the ATP/ADP ratio and CxI decreased, which was reversed in the presence of both proteins. These changes suggest that these immunoreactive proteins are not an artefact of non-specific binding of the anti-NDUFS3 antibody, but represent true proteins which contain NDUFS3 whose expression is integral to the activity of CxI. Other reports have shown that NDUFS3 immunoreactivity is present in more than one protein [37] [38] [39] [40] . Therefore it is likely that the increase in the abundance of these proteins has functional relevance for CxI activity. This increase in protein expression arising from NNMT expression and MeN did not result from increased mRNA synthesis, but instead arose from a decrease in NDUFS3 degradation. This is evidenced by similar changes in NDUFS3 immunoreactive protein abundance in the presence of the lysosomal protease inhibitor leupeptin. Therefore it is likely that NNMT increases CxI activity by reducing the degradation of the CxI subunit NDUFS3. As yet, it is unclear how NNMT and MeN reduce the degradation of NDUFS3. Possibilities include the direct inhibition of protein degradation itself, or the regulation of the expression of genes involved in protein transport or proteolysis. If the mechanism could be elucidated, it may serve as a possible target for drug development studies in PD.
NNMT expression and MeN protect against the toxicity of inhibitors of CxI
Having identified that NNMT expression increases the ATP/ADP ratio by maintaining CxI activity, mediated by a decrease in the degradation of NDUFS3, we wondered whether NNMT may protect against the toxicity of CxI inhibitors. When we exposed S.NNMT.LP cells to the CxI inhibitors MPP+ and rotenone, which were both significantly toxic towards SH-SY5Y cells, we observed that MPP+ was not significantly toxic, and rotenone was significantly less toxic towards S.NNMT.LP cells. This demonstrates that the reduction in pyridine nucleotide synthesis did not leave S.NNMT.LP cells susceptible to further neurotoxic challenge. Further experiments using MeN showed that this neuroprotection occurred via the protection of NDUFS3 from damage by MPP+ and rotenone, resulting in the maintenance of CxI activity and the ATP/ADP ratio. This suggests that MeN is a naturally occurring cytoprotective compound which, if replicated in vivo, raises the possibility of using MeN-based compounds as potential neuroprotective therapies for the treatment of PD.
Our in vitro data provide an insight into the potential cellular consequences of such an increase in NNMT expression in vivo and the mechanism by which it may occur. If our in vitro data were to be replicated in vivo, it raises the intriguing possibility that the significant increase in NNMT expression that we observed in PD patients [6, 8] is not contributing to the pathogenic process of PD, but is instead a stress response of the cell. Although no study has been performed investigating MeN levels in PD patient brain, it is conceivable that the significant increase in NNMT expression observed may be an attempt to raise intracellular levels of MeN in order to increase CxI activity. Such a cytoprotective effect for NNMT is not without precedent. A recent study has shown that NNMT expression is induced in both the cirrhotic liver and experimental hepatitis as a hepatoprotective mechanism in response to the underlying pathogenic process, and that this is mediated by elevated MeN production [41] . Our results also suggest that the overexpression of NNMT in a variety of cancers may be a contributory factor to their accelerated growth, raising the possibility of using NNMT inhibitors for the treatment of cancer.
In conclusion, the expression of NNMT protects the CxI subunit NDUFS3 from degradation, leading to an increase in ATP concentration and CxI activity. These effects are mediated via MeN, the product of nicotinamide N-methylation by NNMT. Furthermore, both NNMT expression and MeN protect undifferentiated SH-SY5Y cells from the toxicity of MPP+ and rotenone by maintaining CxI activity.
